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Second primary carcinomaAbstract The occurrence of second primary carcinomas (SPC) in aerodigestive tract is well recog-
nized in the literature especially the lung and esophagus. The tumors are described according to the
chronological presentation as simultaneous, synchronous and metachronous. Occurrence of second
primary malignancy can be missed in early examination if they are not actively looked for. We are
reporting the ﬁrst and extremely rare presentation of nasopharyngeal carcinoma (NPC) presented
simultaneously with laryngeal carcinoma with literature review and stress on the importance of pan-
endoscopy in the management.
ª 2014 Egyptian Society of Ear, Nose, Throat and Allied Sciences. Production and hosting by Elsevier
B.V. All rights reserved.1. Introduction
Chronological description of multiple tumor occurrences is
divided into synchronous when the second tumor appears
within 6 months of index malignancy, metachronous when
the duration is more than 6 months and simultaneous when
tumors are diagnosed at the same time. Multiple primary
tumors are well known in aerodigestive tract but simultaneous
occurrence of NPC with laryngeal carcinoma is not reported
yet in the English literatures.2. Case report
An eighty year-old male was presented with 6 months history
of hoarseness, dysphagia and stridor for 2 weeks duration.
He denied nasal, otologic and aspiration symptoms. On phys-
ical examination he was cachexic, dehydrated, dyspnoeic with
hoarseness and inspiratory stridor. There was clinical evidence
of bilateral multiple cervical lymphadenopathy with the big-
gest measuring 3 · 3 cm. Awake ﬂexible nasopharyngolaryn-
goscopy examination revealed exophytic mass within the
nasopharynx originating from the right fossa of Rosenmu¨ller
(FOR) and huge exophytic lesion in the supra-glottic region.
Vocal cord movement could not be assessed. In view of the
patient’s clinical condition, an emergency tracheostomy undered.
Figure 1 Contrasted CT scan showing soft tissue density at the
right FOR with extension to the right parapharyngeal space (star).
110 K.S. Kasim et al.local anesthesia was performed followed by direct endoscopic
examination which revealed irregular mass involving the false
and true vocal cords, anterior commissure, laryngeal surface of
the epiglottis and inferior surface of the vocal cords with sub-
glottic extension. Multiple biopsies were taken from the suspi-
cious areas. CT scan showed soft tissue density at the right
FOR extending to the right parapharyngeal space. Fig. 1
and another soft tissue density at the right laryngeal inlet at
the level of the hyoid bone. Fig. 2 chest X-ray showed well
deﬁned nodular and cavitary lesion on the left lobe Fig. 3.Figure 2 Contrasted CT scan at the level of hyoid bone showing s
paraglottic space.Histopathological examination revealed a non-keratinizing
undifferentiated nasopharyngeal carcinoma with WHO classi-
ﬁcation type III and moderately differentiated squamous cell
carcinoma of the larynx. The clinical, radiological and histopa-
thological staging was stage IV with lung metastasis. Due to
the advance stage of the disease palliative management was
planned for the patient.
3. Discussion
Second primary carcinomas represent the leading cause of
death among the head and neck carcinomas. Approximately
one third of the mortality rate is caused by SPC, triple the
number caused by distant metastasis.1 The SPCs demonstrate
the concept of ﬁeld cancerization, in which carcinogens like
tobacco, alcohol, genetic predisposition, environmental fac-
tors, HPV and EBV are known risk factors for head and neck
malignancies; can induce a ﬁeld of mucosal burden with pre-
malignant disease which may elevate the epithelial cancer risk
throughout the upper aerodigestive tract.2
Early detection of SPCs has vast impact on the prognosis
and curative outcomes of the disease and this fact is well doc-
umented in the literature.3
Sandro et al.3 in 358 endoscopic evaluations of patients
with upper aerodigestive malignancies reported that incidence
of second primary carcinoma (SPC) of 16.2% with 6.4% being
synchronous, 9.8% metachronous and 3.1% of cases silent
synchronous tumor was diagnosed.3
Haldun et al. in a study included 1112 patients of head and
neck SCC reported that 7% rate of synchronous detection and
9% metachronous were mainly in the lung.4
Chuang et al in a pooled analysis of 13 center registries
worldwide which included 99,257 patients showed the incidence
of SPC of 10.9%. Lung was the most common site of involve-
ment 30%, esophagus 5% and larynx 1.7%.5 Remarkably, inoft tissue density at the preepiglottic space extending to the right
Figure 3 Chest X-ray showing multiple nodular cavitary lesions involving the left lung (arrow).
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from 1990 till date there were no cases reported of simultaneous
NPC and laryngeal CA.
The role of pan-endoscopy compared to other investiga-
tions such as CT scan, MRI and PET in primary diagnostic
workup has been discussed and even though the ratio of sec-
ond tumor found by endoscopy is low but the most valuable
ﬁnding is the silent asymptomatic simultaneous SPC, which
will inﬂuence the prognosis and a curative outcome. It may
also help to avoid unnecessary mutilating and radical treat-
ment of the primary tumor.6 Jones et al. concluded in contrast
to the overall 5-year survival rate for head and neck cancer
patients of approximately 50%, the 5-year survival rate in head
and neck cancer patients who developed SPC was around 20%
after the SPC was diagnosed. The 5-year survival rates after
SPC diagnosis were above 30% if the SPC was also a head
and neck cancer and decreased to 8% if the SPC was outside
the head and neck area.7
4. Conclusion
In conclusion, SPCs in patients with head and neck cancer are
not uncommon and represent a signiﬁcant obstacle improving
the survival rate. Multiple investigators have demonstrated
that SPCs negatively impact survival in patients with head
and neck cancer. For that reason, careful and detail assessment
is important to rule out synchronous lesion as it affects the
management and the overall prognosis.Conﬂict of interest
None declared.
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